Skip to main content
Log in

Patients, prescribing, and benzodiazepines

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In order to establish the current status of benzodiazepine prescribing and also to assess patients' attitudes towards the use of these drugs, we interviewed 450 consecutive patients in 16 community pharmacies about their use of benzodiazepines.

Prescribing rates increased ten-fold from the age of 20 to 70 years and were higher in women than in men. The average dose used in the elderly seemed excessive and the choice of hypnotic often inappropriate.

The median duration of benzodiazepine use was 2.5 years (range 0–25) and 66% of the patients had been taking benzodiazepines for one year or more.

Most of the patients (97%) found the drugs effective in the treatment of anxiety or insomnia. Twenty-two percent took a lower dose than prescribed and 7.5% a higher dose.

These data suggest that benzodiazepines are prescribed for excessively long periods and that greater caution is needed in prescribing benzodiazepines for older patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Catalan J, Gath DH (1985) Benzodiazepines in general practice: Time for a decision. Br Med J 290: 1374–1376

    Google Scholar 

  2. Tyrer P (1984) Medicine and the media. Br Med J 288: 1531

    Google Scholar 

  3. Cooperstock R, Parnell P (1982) Research on psychotropic drug use. A review of findings and methods. Soc Sci Med 16: 1179–1196

    Google Scholar 

  4. Williams P (1980) The use of prescribed psychotropic medicines. Pub Health Rev 9: 215–247

    Google Scholar 

  5. Bergman U, Dahlstrom M, Gunnarsson C, Westerholm B (1979) Why are psychotropic drugs prescribed to outpatients? Eur J Clin Pharmacol 15: 249–256

    Google Scholar 

  6. Greenblatt DJ, Allen MD (1978) Toxicity of nitrazepam in the elderly: A report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol 5: 407–413

    Google Scholar 

  7. Greenblatt DJ, Allen MD, Shader RI (1977) Toxicity of high-dose flurazepam in the elderly. Clin Pharmacol Ther 21: 355–361

    Google Scholar 

  8. Boston Collaborative Drug Surveillance Program (1973) Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. N Engl J Med 288: 277–280

    Google Scholar 

  9. Uhlenhuth EH, Balter MB, Mellinger GD, Cisin IH, Clinthorne J (1984) Anxiety disorders: prevalence and treatment. Curr Med Res Opin 8 [Suppl 4]: 37–47

    Google Scholar 

  10. British National Formulary (1987) The Pharmaceutical Press, London

  11. Cook PJ, Flanagan R, James IM (1984) Diazepam tolerance: Effect of age, regular sedation and alcohol. Br Med J 289: 351–353

    Google Scholar 

  12. Castleden CM, George CF, Marcer D, Hallett C (1977) Increased sensitivity to nitrazepam in old age. Br Med J 1: 10–12

    Google Scholar 

  13. Swift CJ, Haythorne JM, Clarke P, Stevenson IH (1981) The effect of ageing on measured responses to single doses of oral temazepam. Br J Clin Pharmacol 11: 413–414

    Google Scholar 

  14. Swift CG (1985) Benzodiazepine pharmacodynamics in the elderly. In: O'Malley K, Waddington J (eds) Therapeutics in the elderly. Elsevier Science Publications, Amsterdam New York Oxford

    Google Scholar 

  15. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316: 363–369

    Google Scholar 

  16. Nicholson AN (1986) Hypnotics — their place in therapeutics. Drugs 31: 164–176

    Google Scholar 

  17. Lader M, Petursson H (1983) Rational use of anxiolytic/sedative drugs. Drugs 25: 514–528

    Google Scholar 

  18. Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR (1975) The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55: 347–359

    Google Scholar 

  19. Greenblatt DJ, Divoll MA, Harmatz JS, MacLaughlin DS, Shader RI (1981) Kinetic and clinical effects of flurazepam in young and elderly noninsomniacs. Clin Pharmacol Ther 30: 475–486

    Google Scholar 

  20. Mellinger GP, Balter MB, Uhlenhuth EH (1984) Anti-anxiety agents: Duration of use and characteristics of users in the USA. Curr Med Res Opin 8 [Suppl 4]: 21–35

    Google Scholar 

  21. Hasday JD, Karch FE (1981) Benzodiazepine prescribing in a family medicine centre. J Am Med Assoc 246: 1321–1325

    Google Scholar 

  22. Khan A, Hornblow AR, Walshe JWB (1981) Benzodiazepine dependence: A general practice survey. NZ Med J 94: 19–21

    Google Scholar 

  23. Muller-Oerlinghausen B (1986) Prescription and misuse of benzodiazepines in the Federal Republic of Germany. Pharmacopsychiatry 19: 8–13

    Google Scholar 

  24. Committee on the Review of Medicines (1980) Systemic review of the benzodiazepines. Br Med J 280: 910–912

    Google Scholar 

  25. Marks J (1985) The benzodiazepines: Use, overuse, misuse, abuse. MTP Press, Lancaster

    Google Scholar 

  26. Swift CG, Swift MR, Hamley J, Stevenson IH, Crooks J (1984) Side-effect “tolerance” in elderly long-term recipients of benzodiazepine hypnotics. Age Ageing 13: 335–343

    Google Scholar 

  27. Reinken J, Sparrow M, Campbell AJ (1982) The giving and taking of psychotropic drugs in New Zealand. NZ Med J 95: 489–492

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nolan, L., O'Malley, K. Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol 35, 225–229 (1988). https://doi.org/10.1007/BF00558257

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558257

Key words

Navigation